Navigation Links
Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
Date:9/5/2008

Company Named 2008 Medical Products Industry Leader

DEERFIELD, Ill., Sept. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX) announced today that it has been named 2008 Medical Products Industry Leader of the Dow Jones Sustainability World Index (DJSI World) and the Dow Jones Sustainability North America Index (DJSI North America). This marks the tenth consecutive year that the company has been listed in the DJSI and the seventh year the company has been named Medical Products Industry Leader since the launch of the DJSI in 1999.

Baxter's leadership position resulted from best scores across a number of performance areas including bioethics, codes of conduct, environmental policy/management, occupational health and safety, and social and environmental reporting.

"We believe our efforts in sustainability enhance shareholder value by making Baxter a more competitive company," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer. "Baxter's approach to sustainability inspires innovation and discipline, and reflects the quality of our people and our company culture."

The Dow Jones Sustainability indices, derived from the Dow Jones Global Index, are the world's first benchmarks tracking the financial performance of leading sustainability-driven companies worldwide. The DJSI World Index tracks the financial performance of the top 10 percent of the 2,500 largest companies in the Dow Jones Global Index in terms of social, economic and environmental performance. The DJSI North America Index includes the top 20 percent in each of 57 sectors out of the largest 600 North American companies in the Dow Jones Global Index.

In addition to Baxter's inclusion in the DJSI, the company has been recognized by Innovest Strategic Value Advisors as one of the Global 100 Most Sustainable Corporations in the World and by Corporate Responsibility Officer magazine as one of the 100 Best Corporate Citizens in the United States. Baxter is a member of the Center for Corporate Citizenship at Boston College, the Business Environmental Leadership Council of the Pew Center on Global Climate Exchange, the Chicago Climate Exchange, the U.S. EPA's Climate Leaders, the Ethics & Compliance Officer Association and Hospitals for a Healthy Environment. Baxter endorses the Ceres principles and is an organizational stakeholder of the Global Reporting Initiative.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.


'/>"/>
SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
2. Baxter Declares Quarterly Dividend
3. Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
4. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
5. Baxters Board of Directors Declares Quarterly Dividend
6. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
7. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
8. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
9. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
10. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
11. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire Editorial ... ... putting significant strain on health care systems, in terms of ... rises, so too does the development of innovative and efficient ... effects. Among the many types of cancer treatments, a growing ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ? ... partnerships and joint development activities. , “Dr. Floyd’s career has spanned 30 years ...
(Date:3/22/2017)... 22, 2017  UBM and the Massachusetts Medical ... extended partnership and the third annual Massachusetts Medtech Week. ... 21 st Annual MassMEDIC Conference held in ... 3-4, 2017. MassMEDIC will feature ... President and CEO, Scott Whitaker , at ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
Breaking Biology Technology:
(Date:3/1/2017)... March 1, 2017  Aware, Inc. (NASDAQ: AWRE), a ... Richard P. Moberg has resigned, effective March ... Chief Financial Officer and Treasurer of Aware citing a ... as a member of the Board of Directors of ... co-Chief Executive Officer and co-President, General Counsel has been ...
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
Breaking Biology News(10 mins):